GlassScriptPhysician profile
Ajay Bedekar
NPI 1962478024
$10,444.15
in general payments reported to CMS, 2019-2025
42 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,035 · 2020: $687 · 2021: $2,478 · 2022: $1,527 · 2023: $885 · 2024: $1,673 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,716.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,903.29 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,501.53 | 2019-2025 | Fasenra, Breztri, Bevespi Aerosphere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,460.68 | 2019-2025 | Ofev, Spiriva Respimat |
| Glaxosmithkline, LLC. | $954.94 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $856.81 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $508.42 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Grifols USA, LLC | $363.82 | 2019-2023 | Prolastin-C Liquid |
| Genentech USA, INC. | $315.96 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $242.08 | 2021-2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $219.11 | 2020-2022 | |
| Advanced Respiratory, INC | $203.39 | 2019-2021 | |
| Abbvie INC. | $199.64 | 2021-2025 | |
| United Therapeutics Corporation | $173.89 | 2021-2025 | Tyvaso, Tyvaso |
| La Jolla Pharmaceutical Company | $162.67 | 2020-2022 | |
| Abiomed | $161.70 | 2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Bedekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.